CALR and cancer: This ICD-resistant phenotype stemmed from low endogenous CRT protein levels in cancer cells (i.e. CRTlow-phenotype) which resulted in defective ecto-CRT levels (Figure 1), which further caused severely reduced phagocytic clearance of treated cancer cells, which ultimately lead to the failure of tumor-rejecting immunity [4].